When: Thursday, April 28th, 6pm-8:30pm
Location: HeartFlow 1400 Seaport Blvd., Building B, Redwood City, CA
Medical technology continues to advance at a rapid pace and represents a leading investment sector. According to the MoneyTree report, VCs invested $12.1 billion in 969 deals in the first quarter of 2016, with the highest amounts going to the software industry. The second largest amount went to the biotech industry with $1.8 billion in 118 deals.
California continues to be one of the epicenters of medical technology development in the World. This technology makes its way into emerging markets, however, the specific needs of emerging markets are not fully met by technologies developed abroad. As a result, a number of innovative start-ups have emerged in Brazil and other countries in Latin America to address local market needs.
- What are the recent trends in medical technology development?
- How are these technologies embraced by emerging markets?
- What are the medical technology unmet needs in emerging markets?
- How are local start-ups doing to address these unmet needs?
Join this exclusive discussion with healthtech leaders & investors on how medical technology is shaping health care delivery across Latin America.
Colin Cahill, joined Venrock as a vice president in 2012 and focuses on healthcare investments across sectors and stages from the firm’s Palo Alto office. He currently serves on the Board of Directors of RefleXion Medical and Shockwave Medical and observes on the board of 10x Genomics. Colin has also contributed to several investments in Venrock’s public and cross-over biotech fund, Venrock Healthcare Capital Partners. Venrock, a compound of “Venture” and “Rockefeller”, is a pioneering VC firm formed in 1969 to build upon the successful investing activities of the Rockefeller family that began in the late 1930s. It has offices in Palo Alto, New York, and Cambridge. Venrock helps entreprenerus build some of the world’s most disruptive, successful companies. Its portfolio includes Apple. The firm led Apple’s first venture round and held a board seat for nearly 20 years.
Fred Aslan, Founder & CEO of Adavium Medical, the largest Brazilian medical equipment and clinical diagnostics company. Backed by leading venture capital funds in the United States, the company commercializes a broad portfolio of products via its two divisions: a Clinical Diagnostics division focused on commercializing equipment and reagents to clinical laboratories; and a Medical Device division focused on commercializing equipment and consumables to physician clinics in dermatology, plastic surgery, vascular and gynecology. Adavium Medical partners with leading international companies to bring premium products to Brazil, and develops and commercializes proprietary, value-based complementary products that serve the unmeet needs of the majority of the market. The company has the largest customer base in Brazil in its respective segments and have assembled an experienced team of more than 300 employees that ensure that our fully-integrated commercial platform operates at World-Class standards. Fred s also a BayBrazil Board member and, prior to Adavium Medical, Fred was VP at Venrock and Director of Bus Dev at CuraGen Corporation, a cancer-focused therapeutics company.
John H. Stevens, M.D. is the Chairman and CEO of HeartFlow Inc., a revolutionary, medical software start-up that has received international recognition for exceptional strides in healthcare innovation. The company is changing cardiovascular healthcare through improvements in the accuracy of non-invasive tests for Coronary Artery Disease, the most common form of Heart Disease and the number one killer of men and women in the United States. HeartFlow operates as a SaaS business that processes standard Computed Tomographic (CT) imaging to generate 3D models of patients’ coronary arteries for physicians’ use. HeartFlow is a VC-backed, pre-IPO company that received FDA clearance in 2014. We are based in Redwood City with an existing presence in Europe and Japan Prior to HeartFlow, Dr. Stevens was the Co-Founder and CTO of Heartport, the Co-Founder and Executive Chairman of Amp Resources, Co-Founder and Chairman and CEO of Sundrop Fuels. He has had extensive experience founding, investing and leading technology focused companies and was an Assistant Professor of Cardiovascular Surgery at Stanford University.